Sanginita Chemi.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE753W01010
  • NSEID: SANGINITA
  • BSEID:
INR
41.57
0.81 (1.99%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 246972

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.47 lacs (68.22%) Volume

Shareholding (Mar 2026)

FII

0.19%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

25.40%

Why is Sanginita Chemicals Ltd falling/rising?

28-Jun-2026

As of 27-Jun, Sanginita Chemicals Ltd's stock price has risen to Rs 41.57, reflecting a 1.99% increase, driven by strong short-term performance and positive trading indicators. However, the company faces significant challenges, including operating losses and a high Debt to EBITDA ratio, which could affect its long-term viability.

As of 27-Jun, Sanginita Chemicals Ltd is experiencing a rise in its stock price, currently at Rs 41.57, which reflects an increase of Rs 0.81 or 1.99%. This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 10.32% compared to the Sensex's decline of 0.46%. Additionally, the stock has shown remarkable performance over the past month, with a 54.08% increase, while the Sensex has only risen by 0.10%.<BR><BR>The stock is also trading significantly above its moving averages, indicating a strong bullish trend. Specifically, it is higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Furthermore, it is close to its 52-week high, being only 3.07% away from Rs 25.85.<BR><BR>However, it is important to note that despite the positive price movement, the company faces significant challenges. It has reported operating losses and negative results for the last four consecutive quarters, with a negative EBITDA of Rs -6 cr. The company's ability to service debt is low, as indicated by a high Debt to EBITDA ratio of -2.04 times. Additionally, promoter confidence appears to be waning, with a decrease in their stake by 1.27% over the previous quarter.<BR><BR>In summary, while Sanginita Chemicals Ltd is currently rising in stock price due to strong short-term performance and positive trading indicators, it is simultaneously facing serious fundamental challenges that could impact its long-term viability.

View full answer

What does Sanginita Chemi. do?

11-Jun-2026

Sanginita Chemicals Ltd is a Micro Cap company in the Chemicals & Petrochemicals industry, established in 2003 and transitioned to a Public Limited Company in 2016. As of March 2026, it reported net sales of 43 Cr and a net loss of 6 Cr, with a market cap of 64 Cr.

Overview:<BR>Sanginita Chemicals Ltd operates in the Chemicals & Petrochemicals industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Sanginita Chemicals was initially established in 2003 as a proprietorship and was incorporated as a Private Limited company on December 15, 2005. It transitioned to a Public Limited Company on December 23, 2016. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 43 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: -6 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 64 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A<BR>- Industry P/E: 24<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.47<BR>- Return on Equity: -6.12%<BR>- Price to Book: 1.20<BR><BR>Contact Details:<BR>- Address: 301 3rd Floor Shalin Complex, Sector 11 Gandhi Nagar Gujarat : 382011<BR>- Tel: 91-79-23240270<BR>- Email: sanginitachemicals@yahoo.com<BR>- Website: http://www.sanginitachemicals.co.in

View full answer

How big is Sanginita Chemi.?

11-Jun-2026

As of 10th June, Sanginita Chemicals Ltd has a market capitalization of 64.00 Cr, with Net Sales of 176.45 Cr and a Net Profit loss of 9.68 Cr over the latest four quarters. Shareholder's Funds are 56.14 Cr and Total Assets are valued at 102.30 Cr as of March 2025.

As of 10th June, Sanginita Chemicals Ltd has a market capitalization of 64.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 176.45 Cr. However, it experienced a loss of 9.68 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds amounted to 56.14 Cr and Total Assets were valued at 102.30 Cr.

View full answer

Who are in the management team of Sanginita Chemi.?

11-Jun-2026

The management team of Sanginita Chemi includes Dineshsinh Bhimsinh Chavada (Chairperson & Managing Director), Vijaysinh Dineshsinh Chavda (Whole-time Director), Hansaben Dineshsinh Chavada (Director), and three Independent Directors: Faiyazkhan Pathan, Jagdishkumar Thakor, and Pramodsinh D Dabhi, along with Saroj Jagetia as Company Secretary & Compliance Officer.

The management team of Sanginita Chemi includes the following members:<BR><BR>1. **Dineshsinh Bhimsinh Chavada** - Chairperson & Managing Director<BR>2. **Vijaysinh Dineshsinh Chavda** - Whole-time Director<BR>3. **Hansaben Dineshsinh Chavada** - Director<BR>4. **Faiyazkhan Pathan** - Independent Director<BR>5. **Jagdishkumar Thakor** - Independent Director<BR>6. **Pramodsinh D Dabhi** - Independent Director<BR>7. **Saroj Jagetia** - Company Secretary & Compliance Officer<BR><BR>If you need more specific information about any of these individuals or their roles, feel free to ask!

View full answer

Who are the peers of the Sanginita Chemi.?

11-Jun-2026

Sanginita Chemi.'s peers include Arvee Laborat., Indian Phosphate, Vital Chemtech, and others, with varying management and growth risks. Sanginita Chemi. has a 1-year return of 217.14%, significantly outperforming its peers, which generally show negative returns.

Peers: The peers of Sanginita Chemi. are Arvee Laborat., Indian Phosphate, Vital Chemtech, Jocil, Hindcon Chemical, Par Drugs & Che., Paragon Fine, Indian Emuls, Unilex Colour &C, and Vadivarhe Speci.<BR><BR>Quality Snapshot: Excellent management risk is observed at Paragon Fine and Indian Phosphate, while Average management risk is found at Jocil, Hindcon Chemical, Par Drugs & Che., and Indian Emuls, and the rest have Below Average management risk. Growth is Excellent at Indian Emuls, while Average growth is noted at Indian Phosphate, Jocil, Hindcon Chemical, Par Drugs & Che., and the rest have Below Average growth. Capital Structure is Excellent at Indian Phosphate, Par Drugs & Che., and Paragon Fine, while Good capital structure is seen at Hindcon Chemical and Unilex Colour &C, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: Sanginita Chemi.'s 1-year return is 217.14%, which is higher than the peer with the highest return, Vital Chemtech, at -20.30%, and the peer with the lowest return, Indian Emuls, at -73.32%. Additionally, peers such as Hindcon Chemical, Par Drugs & Che., Indian Emuls, and Unilex Colour &C have negative six-month returns.

View full answer

Should I buy, sell or hold Sanginita Chemicals Ltd?

14-Jan-2026

Are Sanginita Chemicals Ltd latest results good or bad?

10-Jan-2026

Sanginita Chemicals Ltd's latest Q3 FY26 results are poor, reporting a net loss of ₹2.78 crores compared to a profit last year, with revenue down 29.36% year-on-year and negative operating margins, indicating ongoing operational challenges.

Sanginita Chemicals Ltd's latest results for Q3 FY26 indicate a troubling financial performance. The company reported a net loss of ₹2.78 crores, a significant decline from a profit of ₹0.14 crores in the same quarter last year. This marks a stark reversal in profitability and highlights ongoing operational challenges.<BR><BR>Revenue also saw a substantial drop, declining by 29.36% year-on-year to ₹43.47 crores. This represents the third consecutive quarter of revenue contraction, which raises concerns about demand for the company's products. Additionally, the operating margin turned negative at -4.05%, indicating that the core operations are currently loss-making.<BR><BR>The overall financial metrics suggest that Sanginita Chemicals is facing significant headwinds, including deteriorating margins and a challenging market environment. The company's performance is classified as poor, and it is struggling to regain investor confidence amid these ongoing issues.

View full answer

Is Sanginita Chemi. overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, Sanginita Chemi. is considered very attractive and undervalued compared to its peers in the chemicals sector, with a PE ratio of -56.71, an EV to EBITDA of 16.34, and a Price to Book Value of 0.49, despite a year-to-date return of -32.28%.

As of 19 November 2025, the valuation grade for Sanginita Chemi. has moved from attractive to very attractive. The company is currently considered undervalued, especially when compared to its peers in the chemicals and petrochemicals sector. Key ratios include a PE ratio of -56.71, an EV to EBITDA of 16.34, and a Price to Book Value of 0.49, which indicate significant discrepancies in valuation metrics relative to industry standards.<BR><BR>In comparison to peers, Sanginita Chemi. stands out with its very attractive valuation, while companies like Solar Industries and Gujarat Fluoroch are deemed very expensive with PE ratios of 94.38 and 56.8, respectively. The PEG ratio for Sanginita is notably low at 0.00, further supporting its undervaluation narrative. Despite recent stock performance lagging behind the Sensex, with a YTD return of -32.28% compared to the Sensex's 10.18%, the fundamental metrics suggest that Sanginita Chemi. presents a compelling investment opportunity at its current price of 10.51.

View full answer

How has been the historical performance of Sanginita Chemi.?

12-Nov-2025

Sanginita Chemi has experienced fluctuating financial performance, with net sales growing from 148.56 Cr in Mar'23 to 229.68 Cr in Mar'25, but profitability metrics have been inconsistent, with profit before tax peaking at 1.04 Cr in Mar'24 and declining to 0.83 Cr in Mar'25. Despite increased sales and total assets, the operating profit margin remained stable, indicating challenges in cost management.

Answer:<BR>The historical performance of Sanginita Chemi shows a fluctuating trend in net sales and profitability over the years, with significant changes in various financial metrics.<BR><BR>Breakdown:<BR>Sanginita Chemi's net sales increased from 148.56 Cr in Mar'23 to 229.68 Cr in Mar'25, marking a notable growth. However, the total expenditure also rose significantly, from 145.53 Cr in Mar'23 to 224.99 Cr in Mar'25, primarily driven by increased raw material costs and purchases of finished goods. Operating profit, excluding other income, improved slightly from 3.03 Cr in Mar'23 to 4.69 Cr in Mar'25, while the overall operating profit margin decreased from 2.04% in Mar'23 to 2.04% in Mar'25, indicating a stable margin despite rising sales. Profit before tax showed fluctuations, peaking at 1.04 Cr in Mar'24 but dropping to 0.83 Cr in Mar'25. Profit after tax also varied, reaching 0.77 Cr in Mar'24 and slightly declining to 0.62 Cr in Mar'25. The company’s total assets increased from 79.50 Cr in Mar'23 to 102.30 Cr in Mar'25, reflecting growth in shareholder's funds and reserves. Cash flow from operating activities turned positive at 3.00 Cr in Mar'25, contrasting with negative cash flow in the previous year, indicating improved operational efficiency. Overall, while Sanginita Chemi has shown growth in sales and assets, profitability metrics have been inconsistent, reflecting challenges in managing costs and maintaining margins.

View full answer

Who are the top shareholders of the Sanginita Chemi.?

17-Jul-2025

The top shareholder of Sanginita Chemi is Dineshsinh Bhimsinh Chavada with a 15.06% stake, followed by public shareholder Yanamadala Rajeswara Rao at 2.6%. Individual investors hold a combined 59.75%, with no institutional holdings or pledged promoter shares reported.

The top shareholders of Sanginita Chemi include Dineshsinh Bhimsinh Chavada, who holds the highest stake at 15.06%. The highest public shareholder is Yanamadala Rajeswara Rao, with a holding of 2.6%. Additionally, individual investors collectively hold a significant portion of 59.75%. There are no institutional holdings or pledged promoter shares reported.

View full answer

What is the technical trend for Sanginita Chemi.?

09-Jun-2025

As of May 29, 2025, Sanginita Chemi's technical trend is mildly bearish, with mixed signals from indicators like the MACD and RSI, while bearish moving averages and Bollinger Bands suggest a cautious outlook.

As of 29 May 2025, the technical trend for Sanginita Chemi has changed from bearish to mildly bearish. The weekly MACD is mildly bullish, while the monthly MACD remains bearish, indicating mixed signals. The RSI shows no signal on the weekly timeframe but is bullish on the monthly, suggesting potential upward momentum in the longer term. However, both the weekly and monthly Bollinger Bands are bearish, and the daily moving averages are also bearish, reinforcing a cautious outlook. The KST is mildly bullish on the weekly but bearish on the monthly, adding to the mixed sentiment. Dow Theory indicates a mildly bearish stance on the weekly, with no trend on the monthly. Overall, the current technical stance is mildly bearish, driven primarily by the bearish moving averages and Bollinger Bands, despite some mildly bullish indicators on the weekly timeframe.

View full answer

When is the next results date for Sanginita Chemi.?

06-Jun-2025

No Upcoming Board Meetings

Has Sanginita Chemi. declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -2.04 times
  • The company has been able to generate a Return on Equity (avg) of 0.86% signifying low profitability per unit of shareholders funds
2

The company has declared Negative results for the last 4 consecutive quarters

3

Risky - Negative EBITDA

4

Reducing Promoter Confidence

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Chemicals & Petrochemicals

stock-summary
Market cap

INR 64 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

24

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

-6.12%

stock-summary
Price to Book

1.20

Revenue and Profits:
Net Sales:
43 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
130.43%
0%
130.43%
6 Months
310.77%
0%
310.77%
1 Year
305.96%
0%
305.96%
2 Years
132.62%
0%
132.62%
3 Years
128.41%
0%
128.41%
4 Years
107.85%
0%
107.85%
5 Years
83.13%
0%
83.13%

Latest dividend: 0 per share ex-dividend date: Sep-19-2019

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Appointment

31-Aug-2019 | Source : NSE

Sanginita Chemicals Limited has informed the Exchange regarding Appointment of Mr Jigneshkumar Gandhi as Company Secretary & Compliance Officer of the company w.e.f. August 31, 2019.

Book Closure

28-Aug-2019 | Source : NSE

Sanginita Chemicals Limited has informed the Exchange that the Register of Members and Share Transfer Books shall remain closed from September 21, 2019 to September 28, 2019 for the purpose of Annual General Meeting.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND
stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Sanginita Chemicals Ltd has announced 1:2 rights issue, ex-date: 07 May 24

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.39%
EBIT Growth (5y)
-220.45%
EBIT to Interest (avg)
0.05
Debt to EBITDA (avg)
9.58
Net Debt to Equity (avg)
0.26
Sales to Capital Employed (avg)
2.42
Tax Ratio
0.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.19%
ROCE (avg)
1.57%
ROE (avg)
0.86%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.27
EV to EBIT
-14.38
EV to EBITDA
-19.63
EV to Capital Employed
2.01
EV to Sales
0.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.95%
ROE (Latest)
-20.84%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.19%)

Promoter with highest holding

None

Highest Public shareholder

Shah Jayeshkumar (4.2%)

Individual Investors Holdings

65.4%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -13.80% vs -6.01% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -12,560.00% vs 91.38% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "42.97",
          "val2": "49.85",
          "chgp": "-13.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-5.37",
          "val2": "0.98",
          "chgp": "-647.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.43",
          "val2": "0.59",
          "chgp": "-27.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-6.33",
          "val2": "-0.05",
          "chgp": "-12,560.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12.50%",
          "val2": "1.97%",
          "chgp": "-14.47%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -23.91% vs 70.67% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -207.55% vs -41.11% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "90.01",
          "val2": "118.29",
          "chgp": "-23.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.13",
          "val2": "2.55",
          "chgp": "-55.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.27",
          "chgp": "-21.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.57",
          "val2": "0.53",
          "chgp": "-207.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.26%",
          "val2": "2.16%",
          "chgp": "-0.90%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -25.77% vs 82.62% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -600.00% vs -50.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "133.48",
          "val2": "179.83",
          "chgp": "-25.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.63",
          "val2": "3.72",
          "chgp": "-116.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.49",
          "val2": "1.85",
          "chgp": "-19.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-3.35",
          "val2": "0.67",
          "chgp": "-600.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-0.47%",
          "val2": "2.07%",
          "chgp": "-2.54%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -23.17% vs 51.60% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -1,662.90% vs -19.48% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "176.46",
          "val2": "229.68",
          "chgp": "-23.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.00",
          "val2": "4.69",
          "chgp": "-227.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.92",
          "val2": "2.44",
          "chgp": "-21.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-9.69",
          "val2": "0.62",
          "chgp": "-1,662.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.40%",
          "val2": "2.04%",
          "chgp": "-5.44%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
42.97
49.85
-13.80%
Operating Profit (PBDIT) excl Other Income
-5.37
0.98
-647.96%
Interest
0.43
0.59
-27.12%
Exceptional Items
0.00
0.00
Standalone Net Profit
-6.33
-0.05
-12,560.00%
Operating Profit Margin (Excl OI)
-12.50%
1.97%
-14.47%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -13.80% vs -6.01% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -12,560.00% vs 91.38% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
90.01
118.29
-23.91%
Operating Profit (PBDIT) excl Other Income
1.13
2.55
-55.69%
Interest
1.00
1.27
-21.26%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.57
0.53
-207.55%
Operating Profit Margin (Excl OI)
1.26%
2.16%
-0.90%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -23.91% vs 70.67% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -207.55% vs -41.11% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
133.48
179.83
-25.77%
Operating Profit (PBDIT) excl Other Income
-0.63
3.72
-116.94%
Interest
1.49
1.85
-19.46%
Exceptional Items
0.00
0.00
Standalone Net Profit
-3.35
0.67
-600.00%
Operating Profit Margin (Excl OI)
-0.47%
2.07%
-2.54%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -25.77% vs 82.62% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -600.00% vs -50.74% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
176.46
229.68
-23.17%
Operating Profit (PBDIT) excl Other Income
-6.00
4.69
-227.93%
Interest
1.92
2.44
-21.31%
Exceptional Items
0.00
0.00
Standalone Net Profit
-9.69
0.62
-1,662.90%
Operating Profit Margin (Excl OI)
-3.40%
2.04%
-5.44%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -23.17% vs 51.60% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -1,662.90% vs -19.48% in Mar 2025

stock-summaryCompany CV
About Sanginita Chemicals Ltd stock-summary
stock-summary
Sanginita Chemicals Ltd
Micro Cap
Chemicals & Petrochemicals
Initially in 2003, Sanginita Chemicals Limited started as a proprietorship under the name "Sanginita Chemicals" and Mr. Vijaysinh Chavda was the proprietor. On December 15, 2005, Sanginita Chemicals Incorporated as Private Limited under the name and style of 'Sanginita Chemicals Private Limited' by promoters. On December 23, 2016, the Company got converted into a Public Limited Company retaining the name to 'Sanginita Chemicals Limited'.
Company Coordinates stock-summary
Company Details
301 3rd Floor Shalin Complex, Sector 11 Gandhi Nagar Gujarat : 382011
stock-summary
Tel: 91-79-23240270
stock-summary
sanginitachemicals@yahoo.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai